• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Guardant Health, Inc. - Common Stock (NQ:GH)

    90.36 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3
    Open 90.36
    Bid (Size) 90.51 (100)
    Ask (Size) 98.00 (100)
    Prev. Close 90.36
    Today's Range 90.36 - 90.36
    52wk Range 36.36 - 120.74
    Shares Outstanding 101,298,669
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Guardant Health to Report First Quarter 2026 Financial Results on May 7, 2026
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know
    What Happened? A number of stocks fell in the afternoon session after a proposed 2027 federal budget revealed significant spending cuts for key health agenci... 
    Via StockStory
    Topics Government Stocks

    Performance

    YTD
    -11.2%
    -11.2%
    1 Month
    +6.4%
    +6.4%
    3 Month
    -21.3%
    -21.3%
    6 Month
    +33.8%
    +33.8%
    1 Year
    +112.1%
    +112.1%

    More News

    Read More
    News headline image
    1 Healthcare Stock with Exciting Potential and 2 Facing Headwinds
    Via StockStory
    News headline image
    Why Is Guardant Health (GH) Stock Soaring Today
    Via StockStory
    Topics Government Stocks
    Guardant Health Inc (NASDAQ:GH) Posts Strong Q4 Revenue Beat and Bullish 2026 Outlook ↗
    Via Chartmill
    News headline image
    Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metastatic Solid Tumors in Japan
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Why Guardant Health (GH) Stock Is Falling Today
    Via StockStory
    Topics Artificial Intelligence Economy Government
    News headline image
    3 Growth Stocks We Think Twice About
    Via StockStory
    News headline image
    Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
    Via MarketMinute
    Topics Supply Chain
    News headline image
    3 Reasons to Avoid GH and 1 Stock to Buy Instead
    Via StockStory
    Topics Supply Chain
    News headline image
    Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    New Guardant Health/Harris Poll Survey Shows 92% of All Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered Similar to Medicare
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    1 Russell 2000 Stock on Our Watchlist and 2 We Question
    Via StockStory
    Topics Supply Chain
    News headline image
    Guardant Health Launches Coast-to-Coast Screening Tour, Bringing Shield Colon Cancer Blood Test to Over 100 Communities Across America
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
    Via StockStory
    Topics Economy Stocks
    News headline image
    Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Guardant Health, Inc.
    Via Business Wire
    News headline image
    The Great Rotation: Small-Caps Break Record Highs as the 'Catch-Up' Trade Ignites
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know
    Via StockStory
    Topics Economy Government World Trade
    News headline image
    Guardant Health (NASDAQ:GH) Surprises With Q4 CY2025 Sales
    Via StockStory

    Frequently Asked Questions

    Is Guardant Health, Inc. - Common Stock publicly traded?
    Yes, Guardant Health, Inc. - Common Stock is publicly traded.
    What exchange does Guardant Health, Inc. - Common Stock trade on?
    Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Guardant Health, Inc. - Common Stock?
    The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market
    What is the current price of Guardant Health, Inc. - Common Stock?
    The current price of Guardant Health, Inc. - Common Stock is 90.36
    When was Guardant Health, Inc. - Common Stock last traded?
    The last trade of Guardant Health, Inc. - Common Stock was at 04/21/26 04:00 PM ET
    What is the market capitalization of Guardant Health, Inc. - Common Stock?
    The market capitalization of Guardant Health, Inc. - Common Stock is 9.15B
    How many shares of Guardant Health, Inc. - Common Stock are outstanding?
    Guardant Health, Inc. - Common Stock has 9B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.